Card image cap

Anna Eshoo's Public Statements on Issue: Drugs

Office:
Page 1 of 2

Date Title
01/26/2022 Eshoo Introduces Bill to Improve Foreign Drug Manufacturing Reporting
04/30/2021 Rep. Eshoo Applauds FDA Moving to Ban Menthol Cigarettes and Flavored Cigars
09/16/2020 Eshoo and Pallone Blast Administration for Withholding Info on Hydroxychloroquine
08/11/2020 Letter to the Hon. Alex Azar, Secretary of the Dept. of Health and Human Services - Bipartisan Committee Leaders Request Information on COVID-19's Impact on Addiction & Overdose Crisis
01/14/2020 Lawmakers Raise Concerns Over Increased Use of Cocaine and Methamphetamine
10/29/2019 Burgess, Eshoo introduce Ready Reserve Legislation
09/18/2019 Letter to the Hon. Ron DeSantis, Governor of Florida, the Hon. Eric Holcomb, Governor of Indiana, the Hon. Matt Bevin, Governor of Kentucky, the Hon. Janet Mills, Governor of Maine, the Hon. Larry Hogan, Governor of Maryland, the Hon. Charlie Baker, Governor of Massachusetts, Michelle Lujan Grisham, Governor of New Mexico, the Hon. Andrew Cuomo, Governor of New York, the Hon. Roy Cooper, Governor of North Carolina, the Hon. Mike DeWine, Governor of Ohio, the Hon. Kate Brown, Governor of Oregon, the Hon. Tom Wolf, Governor of Pennsylvania, the Hon. Gina Raimondo, Governor of Rhode Island, the Hon. Bill Lee, Governor of Tennessee, the Hon. Jim Justice, Governor of West Virginia, and the Hon. Tony Evers, Governor of Wisconsin - E&C bipartisan leaders seek information from states on use of federal funds to respond to opioid crisis
06/25/2019 Letter to the Hon. Norma Sharpless, Acting Commissioner of the Food and Drug Administration - Bipartisan E&C Leaders Request FDA Briefing on Opioids
06/13/2019 Letter to Various Federal Agencies - Bipartisan E&C Leaders Request Briefings on Ongoing Threat Posed by Fentanyl from Six Federal Agencies
06/13/2019 Letter to the Hon. Kevin McAleenan, James Carroll, Utlam Dhillon, Megan Brennan, Michael Pompeo, and Norman Sharpless - Bipartisan E&C Leaders Request Briefings on Ongoing Threat Posed by Fentanyl From Six Federal Agencies
02/06/2019 Hearing of the Health Subcommittee of the House Committee on Energy and Commerce - Opening Statement of Rep. Anna Eshoo, Hearing on "Texas V. US: the Republican Lawsuit and its Impacts on Americans with Pre-existing Conditions"
06/22/2018 Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act
03/19/2018 Letter to the Hon Tom Cole, Chairman on the Subcommittee on Labor, Health and Human Services, and Education, and the Hon Rosa DeLauro, Ranking Member on the Subcommittee on Labor, Health and Human Services, and Education - Rep. Sewell Leads Funding Letters on Sickle Cell Research, Rural Medicare Payments, Poison Control, and Health Disparities
01/19/2018 Letter to the Hon. Donald J. Trump, President of the United States - Declare Opioid Epidemic a National Emergency
08/22/2017 Letter to the Hon. Donald J. Trump, President - Implementation of Opioid Commission Recommendations
05/16/2017 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding
08/22/2013 Eshoo Leads Bipartisan Coalition Seeking Answers from Treasury on Sequestered FDA User Fees
08/22/2013 Eshoo Casts 40th Vote to Protect Rights of Americans Under Affordable Care Act
05/17/2013 Pitts, Schakowsky, Whitfield and Eshoo Introduce Bill to End Doping of Racehorses
06/01/2012 Food and Drug Administration Reform Act of 2012
05/30/2012 Eshoo's Prescription Drug Bill for Kids Approved by House
03/28/2012 Reps. Eshoo, Markey, Rogers Introduce Legislation to Improve Pediatric Medications
06/16/2011 House Members Introduce Bipartisan Legislation to Combat Drug-Resistant Infections
06/15/2011 Rep. Eshoo and Bipartisan Coalition Introduce Bill to Combat the Rise of Drug-Resistant Infections
06/15/2011 House Members Introduce Bipartisan Bill to Combat the Rise of Drug-Resistant Infections

Page 1 of 2
arrow_upward